Osteopetrosis, Autosomal Recessive 8; Optb8

Table of contents:

Description
Related genes
Clinical Features
Incidence and onset information
Alternative Names
Researches and researchers
Gene Panels
Sources and references

Genes related to Osteopetrosis, Autosomal Recessive 8; Optb8

SNX10

View recommended genes panels

Clinical Features

Top most frequent phenotypes and symptoms related to Osteopetrosis, Autosomal Recessive 8; Optb8

Failure to thrive
Strabismus
Anemia
Feeding difficulties
Hepatomegaly
Macrocephaly
Optic atrophy
Gait disturbance
Frontal bossing
Hypoplasia of the corpus callosum

And another 17 symptoms. If you need more information about this disease we can help you.

Click here to know more about Mendelian.

Incidence and onset information

— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)
— No data available about the known clinical features onset.

Researches and researchers

Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.

Osteopetrosis, Autosomal Recessive 8; Optb8 Recommended genes panels

Panel Name, Specifity and genes Tested/covered
Osteopetrosis autosomal recessive 8 (sequence analysis of SNX10 gene). By CGC Genetics (Portugal). SNX10 Specificity 100 % Genes 100 %
Osteopetrosis via SNX10 Gene Sequencing with CNV Detection. By PreventionGenetics PreventionGenetics (United States). SNX10 Specificity 100 % Genes 100 %
Skeletal Disorders and Joint Problems Sequencing Panel with CNV Detection. By PreventionGenetics PreventionGenetics (United States). RMRP, ROR2, RUNX2, SALL1, BMP1, BMP2, BMPR1B, SF3B4, SH3BP2, FBXW4, SHH, SHOX, SKI, SLCO2A1, SLC26A2, SMARCAL1, SMC1A, SOX9, SQSTM1, TBX15 , (...) View the complete list with 236 more genes Panel complete gene list RMRP, ROR2, RUNX2, SALL1, BMP1, BMP2, BMPR1B, SF3B4, SH3BP2, FBXW4, SHH, SHOX, SKI, SLCO2A1, SLC26A2, SMARCAL1, SMC1A, SOX9, SQSTM1, TBX15, TBX3, TBX4, TBX5, TBX6, TBXAS1, TCF12, TCIRG1, TCOF1, TGFB1, TGFBR1, TGFBR2, TNFRSF11A, TNFRSF11B, TNFSF11, TNXB, TRIP11, TRPS1, ACP5, TWIST1, TYROBP, VDR, CCN6, WNT1, WNT3, WNT5A, WNT7A, ZMPSTE24, ADAMTS10, LMBR1, HDAC8, NSDHL, IFT122, CA2, SOST, HDAC4, NSD1, RAB23, ADAMTSL2, ALX1, SNX10, SERPINH1, ANKH, XYLT1, SALL4, HES7, TP63, PCNT, RAB33B, IFITM5, SRCAP, ACVR1, ADAMTS17, ORC6, CHSY1, SP7, CDC6, CDH3, AFF4, B3GALT6, TRPV4, FKBP10, ASXL1, WDR19, PROK2, FKBP14, RIN2, DOCK6, P3H1, SBDS, CHST3, CANT1, EVC2, GREM1, POLR1C, CLCN7, SLC34A3, SMOC1, TGDS, SULF1, POLR1D, SLC35D1, SLC39A13, CUL7, ANKRD11, DYM, OSTM1, LHX4, ADAMTS2, COL10A1, COL11A1, WDR60, COL11A2, COL1A2, COL3A1, COL5A1, COL5A2, FAM20C, COL9A1, COL9A2, COL9A3, COMP, COL27A1, TRAPPC2, FERMT3, ZNF469, FREM1, CREBBP, CRTAP, BMPER, CHST14, TCTN3, CDT1, SMC3, FAM111A, CTSK, DDX59, CCDC8, TMEM38B, TTC21B, GORAB, IMPAD1, PIGV, CYP27B1, PIEZO2, CEP120, AMER1, ESCO2, DDR2, ANO5, CCNQ, EOGT, DHCR24, DHODH, NIPBL, LEMD3, IFT140, DLL3, OBSL1, ARHGAP31, WDR35, IFT80, DMP1, DYNC2H1, MESP2, TXNL4A, EFTUD2, EBP, ACAN, EFNB1, MEGF8, EIF2AK3, AGPS, ENPP1, EP300, ERF, EVC, EXT1, BHLHA9, EXT2, FBLN1, FBN1, FBN2, FGD1, FGF10, FGF23, FGFR1, FGFR2, FGFR3, FLNA, FLNB, FMN1, GALNT3, GDF3, GDF5, GDF6, GHSR, GLI3, ALPL, GPC3, GPC6, ALX3, ALX4, RIPK4, HOXA11, HOXA13, HOXD13, HPGD, HSPG2, RBPJ, IHH, INPPL1, IRF6, KIF22, LBR, COG1, LFNG, LIFR, LMX1B, LRP4, LRP5, MATN3, MEOX1, MGP, MMP13, MMP2, MMP9, ARSE, MSX2, MYCN, NEK1, NFIX, NOG, NPPC, NPR2, ORC1, ORC4, PAPSS2, PCYT1A, PDE4D, SERPINF1, PEX7, PHEX, PITX1, PLOD1, PLOD2, PLS3, PPIB, B4GALT7, PRKAR1A, NKX3-2, PTDSS1, PTHLH, PTH1R, RAD21, RASGRP2, RECQL4 Specificity 1 % Genes 100 %
Osteopetrosis and Dense bone dysplasia Deletion / Duplication panel. By Connective Tissue Gene Tests (United States). SLCO2A1, TBXAS1, TCIRG1, TGFB1, TNFRSF11A, TNFRSF11B, TNFSF11, TYROBP, CA2, SOST, SNX10, ANKH, CLCN7, OSTM1, FAM20C, FERMT3, CTSK, AMER1, LEMD3, PLEKHM1 , (...) View the complete list with 7 more genes Panel complete gene list SLCO2A1, TBXAS1, TCIRG1, TGFB1, TNFRSF11A, TNFRSF11B, TNFSF11, TYROBP, CA2, SOST, SNX10, ANKH, CLCN7, OSTM1, FAM20C, FERMT3, CTSK, AMER1, LEMD3, PLEKHM1, DLX3, GJA1, HPGD, LRP4, LRP5, MTAP, PTDSS1 Specificity 4 % Genes 100 %
Osteopetrosis Deletion / Duplication panel. By Connective Tissue Gene Tests (United States). TCIRG1, TNFRSF11A, TNFSF11, CA2, SNX10, CLCN7, OSTM1, FAM20C, FERMT3, CTSK, AMER1, LEMD3, PLEKHM1, LRP5 Specificity 8 % Genes 100 %
Osteopetrosis and Dense bone dysplasia NGS panel. By Connective Tissue Gene Tests (United States). SLCO2A1, TBXAS1, TCIRG1, TGFB1, TNFRSF11A, TNFRSF11B, TNFSF11, TYROBP, CA2, SOST, SNX10, ANKH, CLCN7, OSTM1, FAM20C, FERMT3, CTSK, AMER1, LEMD3, PLEKHM1 , (...) View the complete list with 7 more genes Panel complete gene list SLCO2A1, TBXAS1, TCIRG1, TGFB1, TNFRSF11A, TNFRSF11B, TNFSF11, TYROBP, CA2, SOST, SNX10, ANKH, CLCN7, OSTM1, FAM20C, FERMT3, CTSK, AMER1, LEMD3, PLEKHM1, DLX3, GJA1, HPGD, LRP4, LRP5, MTAP, PTDSS1 Specificity 4 % Genes 100 %
Osteopetrosis Comprehensive panel. By Connective Tissue Gene Tests (United States). TCIRG1, TNFRSF11A, TNFSF11, CA2, SNX10, CLCN7, OSTM1, FAM20C, FERMT3, CTSK, AMER1, LEMD3, PLEKHM1, LRP5 Specificity 8 % Genes 100 %
Osteopetrosis and Dense bone dysplasia Comprehensive panel. By Connective Tissue Gene Tests (United States). SLCO2A1, TBXAS1, TCIRG1, TGFB1, TNFRSF11A, TNFRSF11B, TNFSF11, TYROBP, CA2, SOST, SNX10, ANKH, CLCN7, OSTM1, FAM20C, FERMT3, CTSK, AMER1, LEMD3, PLEKHM1 , (...) View the complete list with 7 more genes Panel complete gene list SLCO2A1, TBXAS1, TCIRG1, TGFB1, TNFRSF11A, TNFRSF11B, TNFSF11, TYROBP, CA2, SOST, SNX10, ANKH, CLCN7, OSTM1, FAM20C, FERMT3, CTSK, AMER1, LEMD3, PLEKHM1, DLX3, GJA1, HPGD, LRP4, LRP5, MTAP, PTDSS1 Specificity 4 % Genes 100 %

You can get up to 15 more panels with our dedicated tool

Learn more

Sources and references

You can check the following sources for additional information.

OMIM Rare Disease Search Engine

If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like HEMOCHROMATOSIS, TYPE 1; HFE1 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 3, SUSCEPTIBILITY TO; FSGS3 IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH EHLERS-DANLOS SYNDROME TYPE 2 GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF